GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » Other Operating Expense

WDB coco Co (TSE:7079) Other Operating Expense : 円635 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co Other Operating Expense?

WDB coco Co's Other Operating Expense for the three months ended in Dec. 2023 was 円172 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was 円635 Mil.

WDB coco Co's quarterly Other Operating Expense increased from Jun. 2023 (円158 Mil) to Sep. 2023 (円167 Mil) and increased from Sep. 2023 (円167 Mil) to Dec. 2023 (円172 Mil).

WDB coco Co's annual Other Operating Expense increased from Mar. 2021 (円379 Mil) to Mar. 2022 (円476 Mil) and increased from Mar. 2022 (円476 Mil) to Mar. 2023 (円503 Mil).


WDB coco Co Other Operating Expense Historical Data

The historical data trend for WDB coco Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co Other Operating Expense Chart

WDB coco Co Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Operating Expense
Get a 7-Day Free Trial 255.98 398.44 378.63 475.86 503.41

WDB coco Co Quarterly Data
Mar18 Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.38 138.15 158.22 167.09 171.53

WDB coco Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円635 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WDB coco Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of WDB coco Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


WDB coco Co (TSE:7079) Business Description

Traded in Other Exchanges
N/A
Address
1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines